T3	Subject 0 30	Up to four percent of patients
T4	Treatment 44 52	imatinib
T5	Effect 65 79	hepatotoxicity
T7	Population 0 18	Up to four percent
T8	Drug 44 52	imatinib
T9	Speculation_cue 53 56	may
T6	Adverse_event 57 64	develop
E1	Adverse_event:T6 
A1	Speculated E1